Minireviews
Copyright ©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 658-664
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.658
Figure 3
Figure 3 Phosphorus-lowering effect of nicotinic acid in chronic kidney disease. Mean serum phosphorus concentrations in dyslipidemic patients with stage 3 chronic kidney disease receiving extended release niacin-laropiprant, or placebo. Error bars are standard errors. Reproduced from Ref. [24].